Belite Bio CFO sells 67K ADSs under 10b5-1 plan
Belite Bio’s CFO and director disclosed pre-planned open-market sales of 67,395 ADSs over two trading days.
Rhea-AI Filing Summary
BELITE BIO, INC (BLTE) director and Chief Financial Officer Chuang Hao-Yuan reported open-market sales of 67,395 American depositary shares on September 4 and September 8, 2026. The ADSs were sold at weighted average prices across ranges from $180 to $198.335 per ADS, pursuant to a Rule 10b5-1 trading plan adopted on December 22, 2025.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 67,395 shares
Net Sell
19 txns
Insider
Chuang Hao-Yuan
Role
Chief Financial Officer
Sold
67,395 shs ($12.80M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | American depositary share F1, F2, F17 | 2,200 | $194.2791 | $427K |
| Sale | American depositary share F1, F2, F18 | 4,120 | $195.6041 | $806K |
| Sale | American depositary share F1, F2, F19 | 4,475 | $196.4692 | $879K |
| Sale | American depositary share F1, F2, F20 | 4,605 | $197.2299 | $908K |
| Sale | American depositary share F1, F2, F21 | 2,562 | $198.0454 | $507K |
| Sale | American depositary share F1, F2, F3 | 1,633 | $180.1597 | $294K |
| Sale | American depositary share F1, F2, F4 | 2,000 | $181.0533 | $362K |
| Sale | American depositary share F1, F2, F5 | 2,000 | $182.4926 | $365K |
| Sale | American depositary share F1, F2, F6 | 3,759 | $183.2666 | $689K |
| Sale | American depositary share F1, F2, F7 | 3,569 | $184.5737 | $659K |
| Sale | American depositary share F1, F2, F8 | 3,872 | $185.2809 | $717K |
| Sale | American depositary share F1, F2, F9 | 4,600 | $186.345 | $857K |
| Sale | American depositary share F1, F2, F10 | 3,900 | $187.1645 | $730K |
| Sale | American depositary share F1, F2, F11 | 1,900 | $188.5884 | $358K |
| Sale | American depositary share F1, F2, F12 | 6,200 | $189.2244 | $1.17M |
| Sale | American depositary share F1, F2, F13 | 1,800 | $190.6331 | $343K |
| Sale | American depositary share F1, F2, F14 | 6,200 | $191.0893 | $1.18M |
| Sale | American depositary share F1, F2, F15 | 3,398 | $192.4038 | $654K |
| Sale | American depositary share F1, F2, F16 | 4,602 | $193.1176 | $889K |
Holdings After Transaction:
American depositary share — 26,038 shares (Direct)
Footnotes (21)
- F1. Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.
- F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/22/2025.
- F3. Represents the weighted average price of shares sold at prices that ranged from $180 to $180.9. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F4. Represents the weighted average price of shares sold at prices that ranged from $181 to $181.92. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F5. Represents the weighted average price of shares sold at prices that ranged from $182 to $182.92. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F6. Represents the weighted average price of shares sold at prices that ranged from $183 to $183.71. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F7. Represents the weighted average price of shares sold at prices that ranged from $184 to $184.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F8. Represents the weighted average price of shares sold at prices that ranged from $185 to $185.95. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F9. Represents the weighted average price of shares sold at prices that ranged from $186.08 to $186.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F10. Represents the weighted average price of shares sold at prices that ranged from $187 to $187.78. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F11. Represents the weighted average price of shares sold at prices that ranged from $188 to $188.9. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F12. Represents the weighted average price of shares sold at prices that ranged from $189 to $189.495. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F13. Represents the weighted average price of shares sold at prices that ranged from $190 to $190.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F14. Represents the weighted average price of shares sold at prices that ranged from $191 to $191.68. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F15. Represents the weighted average price of shares sold at prices that ranged from $192 to $192.85. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F16. Represents the weighted average price of shares sold at prices that ranged from $193 to $193.51. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F17. Represents the weighted average price of shares sold at prices that ranged from $194 to $194.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F18. Represents the weighted average price of shares sold at prices that ranged from $195 to $195.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F19. Represents the weighted average price of shares sold at prices that ranged from $196 to $196.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F20. Represents the weighted average price of shares sold at prices that ranged from $197 to $197.845. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F21. Represents the weighted average price of shares sold at prices that ranged from $198 to $198.335. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Key Figures
Total ADSs sold: 67,395 shares
Number of sale transactions: 19
Lowest weighted average sale price range: $180 to $180.9 per ADS
+4 more
7 metrics
Total ADSs sold
67,395 shares
Aggregate non-derivative sales reported in this Form 4
Number of sale transactions
19
Individual non-derivative sale entries on September 4 and 8, 2026
Lowest weighted average sale price range
$180 to $180.9 per ADS
Footnote for the September 4, 2026 sale block with price range
Highest weighted average sale price range
$198 to $198.335 per ADS
Footnote for the September 8, 2026 sale block with price range
Example weighted average price
$180.1597 per ADS
Sale of 1,633 ADSs on September 4, 2026
Example higher weighted average price
$198.0454 per ADS
Sale of 2,562 ADSs on September 8, 2026
Rule 10b5-1 plan adoption date
December 22, 2025
Date the reporting person adopted the trading plan governing these sales
Key Terms
American depositary share, Rule 10b5-1 trading plan, weighted average price
3 terms
Rule 10b5-1 trading plan regulatory
"sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"Represents the weighted average price of shares sold at prices that ranged from"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BLTE report in this Form 4?
BELITE BIO, INC reported that its CFO and director, Chuang Hao-Yuan, sold 67,395 American depositary shares in open-market transactions on September 4 and 8, 2026.
Were the BLTE insider sales made under a Rule 10b5-1 plan?
Yes. A footnote states that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2025.
How many BLTE ADSs were sold on this Form 4 in total?
According to the transaction summary, the reporting person sold a total of 67,395 American depositary shares, all classified as non-derivative open-market or private transactions.
On which dates did the BLTE CFO’s reported sales occur?
The reported sales of American depositary shares occurred on September 4, 2026 and September 8, 2026, across multiple transaction blocks on each date.
AI-generated analysis. How Rhea-AI works. Not financial advice.